Satellos Bioscience Inc. (MSLE) Stock

NASDAQ: MSLEHealthcare company in the biotechnology industry, based in Toronto, ON.

Satellos Bioscience stock price chart

MSLE interactive chart →

MSLE stock quote & key statistics

Satellos Bioscience earnings per share

Income →
Earnings per share

Satellos Bioscience revenue & net income

Income →
RevenueNet income

Satellos Bioscience annual financials

Income statement →
Fiscal yearRevenueNet incomeEPS
FY2025$0-$24.9M-$1.76
FY2024$0-$19.6M-$1.99
FY2023$0-$12.0M-$1.58
FY2022$0-$11.3M-$2.77
FY2021$0-$15.5M-$6.27

Fiscal year ending December 31. Source: company filings via EODHD.

About Satellos Bioscience Inc.

Satellos Bioscience Inc., a clinical-stage drug development company, focuses on restoring natural muscle repair and regeneration in degenerative muscle diseases in Canada, the United States, and Australia. The company uses its proprietary discovery platform MyoReGenX, an automated microscopy system that recapitulates the muscle stem cell environment ex-vivo. It develops SAT-3247, an oral, small molecule drug candidate for the treatment of Duchenne muscular dystrophy disease.

The company has a license agreement the with Ottawa Hospital Research Institute (OHRI); and an option agreement with the University of British Columbia. Satellos Bioscience Inc. was founded in 2018 and is headquartered in Toronto, Canada.

Satellos Bioscience stock FAQ

What is the Satellos Bioscience stock ticker symbol?

Satellos Bioscience Inc. trades on the NASDAQ under the ticker symbol MSLE.

What sector and industry is Satellos Bioscience in?

Satellos Bioscience Inc. is classified in the Healthcare sector, Biotechnology industry.

How many employees does Satellos Bioscience have?

Satellos Bioscience Inc. has about 18 full-time employees.

What were Satellos Bioscience's revenue and earnings last fiscal year?

Satellos Bioscience reported revenue of $0 and net income of -$24.9M in fiscal 2025, with earnings per share of -$1.76.

When did Satellos Bioscience go public?

Satellos Bioscience stock began trading on February 6, 2026.

Biotechnology stocks

All Healthcare stocks →